IGC Pharma Files 8-K on Security Holder Votes
Ticker: IGC · Form: 8-K · Filed: Aug 27, 2024 · CIK: 1326205
| Field | Detail |
|---|---|
| Company | Igc Pharma, Inc. (IGC) |
| Form Type | 8-K |
| Filed Date | Aug 27, 2024 |
| Risk Level | low |
| Pages | 3 |
| Reading Time | 3 min |
| Sentiment | neutral |
Sentiment: neutral
Topics: corporate-governance, filing-update
TL;DR
IGC Pharma filed an 8-K on 8/27 for votes on 8/23.
AI Summary
IGC Pharma, Inc. filed an 8-K on August 27, 2024, reporting on matters submitted to a vote of security holders and other events. The filing date for the earliest event reported is August 23, 2024. The company, formerly known as India Globalization Capital, Inc., is incorporated in Maryland and operates in the pharmaceutical preparations sector.
Why It Matters
This filing indicates that IGC Pharma is engaging in corporate actions requiring shareholder approval, which could impact the company's future direction and governance.
Risk Assessment
Risk Level: low — The filing is a routine 8-K reporting on corporate events and does not disclose immediate financial distress or significant operational changes.
Key Numbers
- 001-32830 — SEC File Number (Identifies the company's filing history with the SEC.)
- 20-2760393 — IRS Employer Identification No. (Company's tax identification number.)
Key Players & Entities
- IGC Pharma, Inc. (company) — Registrant
- India Globalization Capital, Inc. (company) — Former company name
- August 23, 2024 (date) — Earliest event reported date
- August 27, 2024 (date) — Filing date
- Maryland (jurisdiction) — State of incorporation
FAQ
What specific matters were submitted to a vote of security holders on or before August 23, 2024?
The filing does not detail the specific matters submitted to a vote of security holders, only that such matters were reported on.
What were the 'Other Events' reported in this 8-K filing?
The filing indicates 'Other Events' were reported but does not specify what those events were.
What is the significance of the filing date being August 27, 2024, for an event on August 23, 2024?
This indicates a standard reporting timeline where events are disclosed within a few business days.
What industry does IGC Pharma, Inc. operate in?
IGC Pharma, Inc. operates in the Pharmaceutical Preparations sector, SIC code 2834.
When did IGC Pharma, Inc. change its name from India Globalization Capital, Inc.?
The company changed its name from India Globalization Capital, Inc. on May 5, 2005.
Filing Stats: 806 words · 3 min read · ~3 pages · Grade level 9.8 · Accepted 2024-08-26 18:38:55
Filing Documents
- igc20240826_8k.htm (8-K) — 38KB
- ex_718723.htm (EX-99.1) — 8KB
- igc20240826_8kimg001.jpg (GRAPHIC) — 4KB
- 0001185185-24-000851.txt ( ) — 195KB
- igc-20240823.xsd (EX-101.SCH) — 3KB
- igc-20240823_def.xml (EX-101.DEF) — 10KB
- igc-20240823_lab.xml (EX-101.LAB) — 19KB
- igc-20240823_pre.xml (EX-101.PRE) — 11KB
- igc20240826_8k_htm.xml (XML) — 3KB
07
Item 5.07 Submission of Matters to a Vote of Security Holders. On August 23, 2024, IGC Pharma, Inc. (the "Company") held its 2024 Annual Meeting of Stockholders (the "Annual Meeting"). At the Annual Meeting the Company's stockholders (i) elected Mr. Richard Prins and Mr. Terry Lierman to the Company's board of directors to serve as Class B directors until the 2027 annual meeting of Stockholders; (ii) ratified the appointment of Manohar Chowdhry & Associates as the Company's independent registered public accounting firm for the 2025 fiscal year; and (iii) approved the grant of 5,000,000 shares of common stock to be granted from time to time to the Company's current and new employees, advisors, directors, and consultants by the board of directors, pursuant to certain metrics including performance, vesting, and incentive as set by the board of directors and or the CEO. The total number of shares of the Company's common stock voted in person or by proxy at the Annual Meeting was 42,811,367 shares, representing approximately 56.60% of the 75,636,419 shares outstanding and entitled to vote at the Annual Meeting. We received a total of 14,877,728 broker non-votes. The director nominees were elected and each other matter submitted to a vote of the Company's stockholders at the Annual Meeting was approved by the requisite vote. The final voting results for each proposal that passed are set forth below. 1. Election of Directors. Nominee For Withhold Broker Non-votes Richard Prins 26,116,740 1,816,899 14,877,728 Terry Lierman 27,800,503 133,136 14,877,728 2. Proposal to ratify the appointment of Manohar Chowdhry & Associates as the Company's independent registered public accounting firm for the 2025 fiscal year. For Against Abstain 42,587,128 165,701 58,538 3. Approval of the grant of 5,000,000 shares of common stock to be granted from time to time to the Company's current and new employees, advisors, directors, and consultants by the b
01
Item 8.01. Other Events. On August 23, 2024, IGC Pharma, Inc. held the Annual Meeting, as previously scheduled. All the proposals passed. A copy of the press release announcing the results of the Annual Meeting voting is attached hereto as Exhibit 99.1.
Financial Statements and Exhibits
Financial Statements and Exhibits. (d) Exhibits. Exhibit No. Description 99.1 Press Release dated August 26, 2024. 104 Cover Page Interactive Data File (formatted as Inline XBRL and contained in Exhibit 101)
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized. IGC PHARMA, INC. Dated: August 26, 2024 By: /s/ Ram Mukunda Name: Ram Mukunda Title: Chief Executive Officer and President